Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of acute myeloid leukemia with intermediate-dose cytosine arabinoside and mitoxantrone.

× No keyword cloud information.

5 in total

1. Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy.

Authors: R A Schwendener; H H Fiebig; M R Berger; D P Berger
Journal: Cancer Chemother Pharmacol Date: 1991 Impact factor: 3.333

Review 2. Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia.

Authors: C J Dunn; K L Goa
Journal: Drugs Aging Date: 1996-08 Impact factor: 3.923

3. High-dose ara-C and etoposide in refractory or relapsing acute leukemia.

Authors: M Freund; H Link; H Diedrich; S LeBlanc; H J Wilke; H Poliwoda
Journal: Cancer Chemother Pharmacol Date: 1991 Impact factor: 3.333

4. Prognostic significance of cytochemical analysis of leukemic M2 blasts.

Authors: M Suĭć; D Boban; M Marković-Glamocak; M Petrovecki; M Marusić; B Labar
Journal: Med Oncol Tumor Pharmacother Date: 1992

5. Five-day 4'-(9-acridinylamino)methanesulphon-m-anisidide and intermediate-dose cytosine arabinoside in high-risk relapsing or refractory acute myeloid leukemia.

Authors: M Freund; S Giller; F Hinrichs; A Baars; J Meran; A Körfer; H Link; H Poliwoda
Journal: J Cancer Res Clin Oncol Date: 1991 Impact factor: 4.553

5 in total